Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment

Journal of Neurochemistry

Volumn 92, Issue 2, 2005, Pages 255-263

  Ahmed, Naila ^a   Ahmed, Usman ^a   Thornalley, Paul J ^a   Hager, Klaus ^b   Fleischer, Gerd ^c   Münch, Gerald ^c,d  

^a UNIVERSITY OF ESSEX   (United Kingdom)

^b Geriatrie der Henriettenstiftung   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d JAMES COOK UNIVERSITY   (Australia)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Glycation; Methylglyoxal; Nitrotyrosine; Oxidative stress

Indexed keywords

3 DEOXYGLUCOSONE; 3 NITROTYROSINE; 6 N CARBOXYETHYLLYSINE; 6 N CARBOXYMETHYLLYSINE; FORMYLKYNURENINE; FRUCTOSYL LYSINE; GLYOXAL DERIVATIVE; HYDROIMIDAZOLONE; IMIDAZOLE DERIVATIVE; LYSINE DERIVATIVE; METHIONINE SULFOXIDE; METHYLGLYOXAL; N DELTA (5 HYDRO 4 IMIDAZOLON 2 YL)ORNITHINE; N DELTA (5 HYDRO 5 METHYL 4 IMIDAZOLON 2 YL)ORNITHINE; N DELTA [5 HYDRO (2,3,4 TRIHYDROXYBUTYL) 4 IMIDAZOLON 2 YL]ORNITHINE; PENTOSIDINE; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; NITRATION; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CEREBROSPINAL FLUID PROTEINS; COGNITION DISORDERS; FEMALE; GLYCOSYLATION; HUMANS; LYSINE; MALE; NEUROPSYCHOLOGICAL TESTS; NITRATES; NITROSO COMPOUNDS; OXIDATION-REDUCTION; REFERENCE VALUES; TYROSINE;

EID: 13244270042     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02864.x     Document Type: Article

References (49)

1. Abordo E. A., Minhas H. S. and Thornalley P. J. (1999) Accumulation of α-oxoaldehydes during oxidative stress. A role in cytotoxicity. Biochem. Pharmacol. 58, 641-648.
2. ε-(1-carboxyethyl) lysine-modified albumin. Biochem. J. 364, 1-14.
3. Ahmed N., Thornalley P. J., Dawczynski J., Franke S., Strobel J., Stein G. and Haik J. R. G. M. (2003) Methylglyoxal-derived hydroimidazolone advanced glycation endproducts of human lens proteins. Invest. Ophthalmol. Vis. Sci. 44, 5287-5292.
4. ε-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol. Aging 24, 333-338.
5. Brot N. and Weissbach H. (1983) Biochemistry and physiological role of methionine sulfoxide reductase in proteins. Arch. Biochem. Biophys. 253, 271-281.
6. Calabrese V., Scapagnini G., Ravagna A., Bella R., Foresti R., Bates T. E., Stella A. M. G. and Pennisi G. (2002) Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J. Neurosci. Res. 70, 580-587.
7. Castegna A., Thongboonkerd V., Klein J. B., Lynn B., Markesbery W. R. and Butterfield D. A. (2003) Proteomic identification of nitrated proteins in Alzheimer's disease brain. J. Neurochem. 85, 1394-1401.
8. ε-(carboxymethyl) lysine and hexitol-lysine. Free Rad. Biol. Med. 31, 175-180.
9. Chen F., Wollmer M. A., Hoerndli F., Munch G., Kuhla B., Rogaev E. I., Tsolaki M., Papassotiropoulos A. and Gotz J. (2004) Role for glyoxalase I in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101, 7687-7692.
10. Cross A. H., Manning P. T., Keeling R. M., Schmidt R. E. and Misko T. P. (1998) Peroxynitrite formation within the central nervous system in active multiple sclerosis. J. Neuroimmunol. 88, 45-56.
11. DeKosky S. T. and Marek K. (2003) Looking backward to move forward: early detection of neurodegenerative disorders. Science 302, 830-834.
12. Erhola H., Leinonen J. S., Erhola M., Lonnrot K. and Aejmelaeus R. (1998) Assay of antioxidant capacity of human plasma and CSF in aging and disease. Restor. Neurol. Neurosci. 12, 159-165.
13. Gaut J. P., Byun J., Tran H. D. and Heinecke J. W. (2002) Artifact-free quantitation of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry. Anal. Biochem. 300, 252-259.
14. Geibauf A., van Wickem B., Simat T., Steinhart H. and Esterbauer H. (1996) Formation of N-formylkynurenine suggests the involvement of apolipoprotein B-100 centered tryptophan radicals in the initiation of LDL lipid peroxidation. FEBS Lett. 389, 136-140.
15. Goldberg A. L. (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426, 895-899.
16. Good P. F., Werner P., Hsu A., Olanow C. W. and Perl D. P. (1996) Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149, 21-28.
17. Good P. F., Hsu A., Werner P., Perl D. P. and Olanow C. W. (1998) Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57, 338-342.
18. Hensley K., Maidt M. L., Yu Z., Sang H., Markesbery W. R. and Floyd R. A. (1998) Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J. Neurosci. 18, 8126-8132.
19. εe-(carboxymethyl) lysine in hippocampal CA4 pyramidal neurons of aged human brain. Pathol. Int. 52, 563-571.
20. Kaur H., Lyras L., Jenner P. and Halliwell B. (1998) Artefacts in HPLC detection of 3-nitrotyrosine in human brain tissue. J. Neurochem. 70, 2220-2223.
21. Kimura T., Takamatsu J., Ikeda K., Kondo A., Miyakawa T. and Horiuchi S. (1996) Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons. Neurosci. Lett. 208, 53-56.
22. Kukull W., Larson E., Teri L., Bowen J., McCormick W. and Pfanschmidt M. L. (1994) The Mini-Mental state examination score and the clinical diagnosis. J. Clin. Epidemiol. 47, 1061-1067.
23. Luth H. J., Munch G. and Arendt T. (2002) Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res. 953, 135-143.
24. Lyras L., Cairns N. J., Jenner A., Jenner P. and Halliwell B. (1997) An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 2061-2069.
25. May C., Kaye J. A., Atack J. R., Schapiro M. B., Friedland R. P. and Rapoport S. I. (1990) Cerebrospinal fluid production is reduced in healthy aging. Neurology 40, 500-503.
26. Mckhann G., Drachman D., Folstein M., Katzman R., Price D. and Stadlan E. M. (1984) Clinical diagnosis of Alzheimer's disease - report of the Nincds-Adrda Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944.
27. McLellan A. C., Thomalley P. J., Benn J. and Sonksen P. H. (1994) The glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. 87, 21-29.
28. Munch G., Apelt J., Rosemarie K. E., Stahl P., Luth H. J. and Schliebs R. (2003) Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology. J. Neurochem. 86, 283-289.
29. Murray J., Taylor S. W., Zhang B., Ghosh S. S. and Capaldi R. A. (2003) Oxidative damage to mitochondrial complex I due to peroxynitrite. J. Biol. Chem. 278, 37 223-37 230.
30. ε- (carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose. Diabetes 51, 2833-2839.
31. Pryor W. A., Jin X. and Squadrito G. L. (1994) One electron and two electron oxidations of methionine by peroxynitrite. Proc. Natl. Acad. Sci. USA 91, 11 173-11 177.
32. Quijano C., Alvarez B., Gatt R. M., Augusto O. and Radi R. (1997) Pathways of peroxynitrite oxidation of thiol groups. Biochem. J. 322, 167-173.
33. Rosen W. G., Mohs R. C. and Davis K. L. (1984) A new rating-scale for Alzheimer's disease. Am. J. Psychiatry 141, 1356-1364.
34. Ryberg H., Soderling A. S., Davidsson P., Blennow K., Caidahl K. and Persson L. I. (2004) Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease. Neurochem. Internatl 45, 57-62.
35. Sasaki S., Shibata N., Komori T. and Iwata M. (2000) iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis. Neurosci. Lett. 291, 44-48.
36. Schwarcz R. and Pellicciari R. (2002) Manipulation of brain kynurenines: glial targets, neuronal effects and clinical opportunities. J. Pharmacol. Exp. Ther. 303, 1-10.
37. Shuvaev V. V., Laffont I., Serot J.-M., Fujii J., Taniguchi N. and Siest G. (2001) Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol. Aging 22, 397-402.
38. Silverberg G. D., Heit G., Huhn S., Jaffe R. A., Chang S. D., Bronte-Stewart H., Rubenstein E., Possin K. and Saul T. A. (2001) The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type. Neurology 57, 1763-1766.
39. Simat T., Meyer K. and Steinhart H. (1994) Synthesis and analysis of oxidation and carbonyl condensation products of tryptophan. J. Chromatogr. A 661, 93-99.
40. Smith M. A., Taneda S., Richey P. L., Miyata S., Yan S.-D., Stern D., Sayre L. M., Monnier V. M. and Perry G. (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl Acad. Sci. USA 91, 5710-5714.
41. Smith M. A., Richey Harris P. L., Sayre L. M., Beckman J. S. and Perry G. (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17, 2653-2657.
42. 1-42 and increased tau levels in CSF of AD subjects. JAMA 289, 2094-2103.
43. Thornalley P. J. (1999) Clinical significance of glycation. Clin. Lab. 45, 263-273.
44. Thornalley P. J., Battah S., Ahmed N., Karachalias N., Agalou S., Babaei-Jadidi R. and Dawnay A. (2003) Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem. J. 375, 581-592.
45. Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E. and Isobe C. (1999) Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neuroscid. Lett. 269, 52-54.
46. Ueno H., Segawa T., Hasegawa T., Nakamuro K. and Maeda H. (1991) Subchronic oral toxicity of glyoxal via drinking water in rats. Fundam. Appl. Toxicol. 16, 763-772.
47. Wada H. (1998) Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio. Intern. Med. 37, 509-513.
48. Wells-Knecht M. C., Lyons T. J., McCance D. R., Thorpe S. R. and Baynes J. W. (1997) Age-dependent increases in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. J. Clin. Invest. 100, 839-846.
49. Wong A., Luth H.-J., Conrad W.-D., Dukic-Stefanovic S., Gasic-Milenkovic J., Arendt T. and Munch G. (2001) Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. Brain Res. 920, 32-40.